当前蛋白身份:Q9L4P2 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
4JF4 OXA-23 meropenem complex 提交 2013-02-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 31–273(243 aa)
未记录 EDO 1,2-ETHANEDIOL × 1 MER (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-d ihydro-1H-pyrrole-2-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.1;277 K;0.06 M citric acid/0.04 M bis-tris propane, 16 % PEG3350, pH 4.1, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.14 Å R-free 0.254
4JF4 OXA-23 meropenem complex 提交 2013-02-27 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 31–273(243 aa)
未记录 MER (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-d ihydro-1H-pyrrole-2-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.1;277 K;0.06 M citric acid/0.04 M bis-tris propane, 16 % PEG3350, pH 4.1, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.14 Å R-free 0.254
4JF5 Structure of OXA-23 at pH 4.1 提交 2013-02-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 31–273(243 aa)
未记录 FLC CITRATE ANION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.1;277 K;0.06 M citric acid/0.04 M bis-tris propane, 16 % PEG3350, pH 4.1, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.15 Å R-free 0.162
4JF6 Structure of OXA-23 at pH 7.0 提交 2013-02-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 31–273(243 aa)
非标准单体:是(mmCIF未提供具体位点) K POTASSIUM ION × 1 CL CHLORIDE ION × 4 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;0.2 M succinic acid, 20% PEG3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.50 Å R-free 0.285
4K0W X-ray crystal structure of OXA-23 A220 duplication clinical variant 提交 2013-04-04 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 31–273(243 aa) 片段:unp residues 31-273
突变:A220 insertion CIT CITRIC ACID × 1 EDO 1,2-ETHANEDIOL × 4 BCT BICARBONATE ION × 4 NA SODIUM ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.2;296 K;0.2M sodium chloride, 0.1M phosphate, 0.1M citrate 20% w/v PEG 8000 , pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 296K
分辨率 1.20 Å R-free 0.202
4K0X X-ray Crystal Structure of OXA-23 from Acinetobacter baumannii 提交 2013-04-04 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 31–273(243 aa) 片段:UNP residues 31-273
非标准单体:是(mmCIF未提供具体位点) BCT BICARBONATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;296 K;5% w/v PGA-LM, 30% v/v PEG 550MME,0.1M Sodium acetate, OXA-23 in 50 mM sodium phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 296K
分辨率 1.61 Å R-free 0.192
6N6T OXA-23 mutant F110A/M221A low pH form 提交 2018-11-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 31–273(243 aa) 片段:UNP residues 31-273
突变:F110A/M221A FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.1;293 K;0.06 M citric acid, 0.04 M bis-Tris propane, pH 4.1, 16% PEG3350
分辨率 1.25 Å R-free 0.180
6N6U OXA-23 mutant F110A/M221A low pH form imipenem complex 提交 2018-11-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 32–273(242 aa) 片段:UNP residues 32-273
突变:F110A/M221A ID1 Imipenem × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.1;293 K;0.06 M citric acid, 0.04 M bis-Tris propane, pH 4.1, 16% PEG3350
分辨率 1.55 Å R-free 0.196
6N6V OXA-23 mutant F110A/M221A low pH form meropenem complex 提交 2018-11-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 32–273(242 aa) 片段:UNP residues 32-273
突变:F110A/M221A KE1 meropenem, bound form × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.1;293 K;0.06 M citric acid, 0.04 M bis-Tris propane, pH 4.1, 16% PEG3350
分辨率 1.55 Å R-free 0.192
6N6W OXA-23 mutant F110A/M221A neutral pH form 提交 2018-11-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 36–273(238 aa) 片段:UNP residues 36-273
突变:F110A/M221A 非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.2 M succinic acid, pH 7.0, 20% PEG3350
分辨率 3.25 Å R-free 0.290
6N6X OXA-23 mutant F110A/M221A neutral pH form imipenem complex 提交 2018-11-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 35–273(239 aa) 片段:UNP residues 35-273
突变:F110A/M221A 非标准单体:是(mmCIF未提供具体位点) ID1 Imipenem × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.2 M succinic acid, pH 7.0, 20% PEG3350
分辨率 3.10 Å R-free 0.216
6N6Y OXA-23 mutant F110A/M221A neutral pH form meropenem complex 提交 2018-11-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 35–273(239 aa) 片段:UNP residues 35-273
突变:F110A/M221A 非标准单体:是(mmCIF未提供具体位点) KE1 meropenem, bound form × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.2 M succinic acid, pH 7.0, 20% PEG3350
分辨率 3.50 Å R-free 0.300
9NSW apo-OXA-23, pH 7.5 提交 2025-03-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
非标准单体:是(mmCIF未提供具体位点) SO4 SULFATE ION × 2 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.40 Å R-free 0.201
9NSX OXA-23-NA-1-157, 3 minute soak 提交 2025-03-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
非标准单体:是(mmCIF未提供具体位点) Y33 (5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.57 Å R-free 0.205
9NSY OXA-23-NA-1-157, 4 minute soak 提交 2025-03-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
非标准单体:是(mmCIF未提供具体位点) Y33 (5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.70 Å R-free 0.229
9NSZ OXA-23-NA-1-157, 6 minute soak 提交 2025-03-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
非标准单体:是(mmCIF未提供具体位点) Y33 (5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid × 1 SO4 SULFATE ION × 1 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.80 Å R-free 0.200
9NT0 OXA-23-meropenem, pH 7.5 提交 2025-03-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
非标准单体:是(mmCIF未提供具体位点) MER (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-d ihydro-1H-pyrrole-2-carboxylic acid × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.60 Å R-free 0.202
9ZOP OXA-23-JDB/PQ-1-219, 3 min soak 提交 2025-12-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
非标准单体:是(mmCIF未提供具体位点) MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.90 Å R-free 0.252
9ZOQ OXA-23-JDB/PQ-1-219, 5 min soak 提交 2025-12-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
非标准单体:是(mmCIF未提供具体位点) MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.65 Å R-free 0.234
9ZOR OXA-23-JDB/PQ-1-219, 10 min complex 提交 2025-12-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
非标准单体:是(mmCIF未提供具体位点) A1C3I (2S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S)-2,3-dihydroazet-3-yl]sulfanyl}-2-methyl-2H-pyrrole-5-carboxylic acid × 1 SO4 SULFATE ION × 2 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.65 Å R-free 0.200
9ZOS OXA-23-JDB/PQ-1-219, 20 min complex 提交 2025-12-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
未记录 A1C3I (2S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S)-2,3-dihydroazet-3-yl]sulfanyl}-2-methyl-2H-pyrrole-5-carboxylic acid × 1 SO4 SULFATE ION × 3 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.60 Å R-free 0.229
9ZOT OXA-23-JDB/PQ-1-219, 30 min complex 提交 2025-12-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
未记录 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 A1C3I (2S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S)-2,3-dihydroazet-3-yl]sulfanyl}-2-methyl-2H-pyrrole-5-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.75 Å R-free 0.198
9ZOU OXA-23-JDB/PQ-1-219, 40 min complex 提交 2025-12-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
未记录 A1C3I (2S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S)-2,3-dihydroazet-3-yl]sulfanyl}-2-methyl-2H-pyrrole-5-carboxylic acid × 1 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.50 Å R-free 0.207
9ZOV OXA-23-JDB/PQ-1-219, 60 min complex 提交 2025-12-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
未记录 CO2 CARBON DIOXIDE × 1 A1C3I (2S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S)-2,3-dihydroazet-3-yl]sulfanyl}-2-methyl-2H-pyrrole-5-carboxylic acid × 1 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.50 Å R-free 0.227
9ZOW OXA-23-JDB/PQ-1-219, 90 min complex 提交 2025-12-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–273(273 aa)
未记录 CO2 CARBON DIOXIDE × 1 A1C3I (2S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S)-2,3-dihydroazet-3-yl]sulfanyl}-2-methyl-2H-pyrrole-5-carboxylic acid × 1 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% PEG3350
分辨率 1.70 Å R-free 0.230